Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2016.11.19
关于增加2016年日常经营性关联交易预计金额的公告
2016.11.19
第三届董事会第二十八次会议决议公告
2016.11.19
关于开展交叉货币掉期业务的可行性分析报告
2016.11.19
关于对全资子公司Hepalink USA Inc.增资的公告
2016.11.19
关于新增募集资金专项存储账户的公告
2016.11.19
关于公司与汇丰银行进行交叉货币掉期交易的公告
2016.11.19
第三届监事会第二十次会议决议公告
2016.11.19
关于全资子公司对外投资的公告
2016.11.10
2016年面向合格投资者公开发行公司债券发行结果公告
2016.11.08
2016年面向合格投资者公开发行公司债券票面利率公告
第一页
上一页
84
85
86
87
88
下一页
最后一页
